Registered number
12857923
DR CELL LIMITED
Annual Report and Unaudited Abridged Financial statement
for the Year Ended 30 September 2021
DR CELL LIMITED
Registered number: 12857923
Balance Sheet
as at 30 September 2021
Notes 2021
£
Current assets
Debtors 3 1,665
Cash at bank and in hand 189
1,854
Creditors: amounts falling due within one year 4 (2,572)
Net current liabilities (718)
Net liabilities (718)
Capital and reserves
Profit and loss account (718)
Shareholders' funds (718)
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Afroz Ali
Director
Approved by the board on 2 September 2022
DR CELL LIMITED
Notes to the Accounts
for the period from 4 September 2020 to 30 September 2021
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 Employees 2021
Number
Average number of persons employed by the company 1
3 Debtors 2021
£
Trade debtors 1,665
4 Creditors: amounts falling due within one year 2021
£
Trade creditors 1,278
Other creditors 1,294
2,572
5 Other information
DR CELL LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
55 London Road,
Croydon,
England,
CR0 2RF
DR CELL LIMITED 12857923 false 2020-09-04 2021-09-30 2021-09-30 VT Final Accounts April 2022 Afroz Ali No description of principal activity 12857923 2020-09-04 2021-09-30 12857923 bus:PrivateLimitedCompanyLtd 2020-09-04 2021-09-30 12857923 bus:AuditExempt-NoAccountantsReport 2020-09-04 2021-09-30 12857923 bus:Director40 2020-09-04 2021-09-30 12857923 1 2020-09-04 2021-09-30 12857923 2 2020-09-04 2021-09-30 12857923 countries:England 2020-09-04 2021-09-30 12857923 bus:FRS102 2020-09-04 2021-09-30 12857923 bus:FullAccounts 2020-09-04 2021-09-30 12857923 2021-09-30 12857923 core:WithinOneYear 2021-09-30 12857923 core:RetainedEarningsAccumulatedLosses 2021-09-30 12857923 2020-09-03 iso4217:GBP xbrli:pure